ArticleScientific reports2025

Indirect treatment comparisons of darolutamide plus docetaxel and androgen deprivation therapy in patients with metastatic hormone-sensitive prostate cancer.

Haiyin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.